Home Focus On Rockland’s Chartwell Pharma says FDA delays cost it $1M

Rockland’s Chartwell Pharma says FDA delays cost it $1M

SHARE

“It is incomprehensible,” the complaint states, that Woodfield “would have so little regard for Chartwell, as its customer, and … efforts at bringing the product to market.”

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email